Haploinsufficiency for Translation Elongation Factor eEF1A2 in Aged Mouse Muscle and Neurons Is Compatible with Normal Function by Griffiths, Lowri A et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Haploinsufficiency for Translation Elongation Factor eEF1A2 in
Aged Mouse Muscle and Neurons Is Compatible with Normal
Function
Citation for published version:
Griffiths, LA, Doig, J, Churchhouse, AMD, Davies, FCJ, Squires, CE, Newbery, HJ & Abbott, CM 2012,
'Haploinsufficiency for Translation Elongation Factor eEF1A2 in Aged Mouse Muscle and Neurons Is
Compatible with Normal Function' PLoS One, vol 7, no. 7, pp. e41917. DOI: 10.1371/journal.pone.0041917
Digital Object Identifier (DOI):
10.1371/journal.pone.0041917
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
PLoS One
Publisher Rights Statement:
Copyright: © 2012 Griffiths et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
Haploinsufficiency for Translation Elongation Factor
eEF1A2 in Aged Mouse Muscle and Neurons Is
Compatible with Normal Function
Lowri A. Griffiths, Jennifer Doig, Antonia M. D. Churchhouse, Faith C. J. Davies, Charlotte E. Squires,
Helen J. Newbery, Catherine M. Abbott*
Centre for Molecular Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom
Abstract
Translation elongation factor isoform eEF1A2 is expressed in muscle and neurons. Deletion of eEF1A2 in mice gives rise to
the neurodegenerative phenotype ‘‘wasted’’ (wst). Mice homozygous for the wasted mutation die of muscle wasting and
neurodegeneration at four weeks post-natal. Although the mutation is said to be recessive, aged heterozygous mice have
never been examined in detail; a number of other mouse models of motor neuron degeneration have recently been shown
to have similar, albeit less severe, phenotypic abnormalities in the heterozygous state. We therefore examined the effects of
ageing on a cohort of heterozygous +/wst mice and control mice, in order to establish whether a presumed 50% reduction
in eEF1A2 expression was compatible with normal function. We evaluated the grip strength assay as a way of distinguishing
between wasted and wild-type mice at 3–4 weeks, and then performed the same assay in older +/wst and wild-type mice.
We also used rotarod performance and immunohistochemistry of spinal cord sections to evaluate the phenotype of aged
heterozygous mice. Heterozygous mutant mice showed no deficit in neuromuscular function or signs of spinal cord
pathology, in spite of the low levels of eEF1A2.
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Introduction
The wasted mouse is a model for early onset severe motor
neuron degeneration [1,2]. The underlying mutation arose in
1972 at the Jackson lab, where it was shown to be recessive and
autosomal [3]. We subsequently found that the primary lesion was
a 15.8 kb deletion which removed the first exon and promoter of
the gene encoding a tissue-specific translation elongation factor
called eEF1A2 [4]. This isoform is closely related to eEF1A1, but
whereas eEF1A1 is almost ubiquitously expressed, eEF1A2 is
expressed only in neurons, cardiac and skeletal muscle [5,6,7]. The
timing of the switch from eEF1A1 to eEF1A2 expression in post-
natal neurons and muscle, which is complete by 21 days, fits
perfectly with the timing of the onset of the phenotype in wasted
mice; wst/wst homozygotes are outwardly normal until 21 days
and then deteriorate and die within the next 7 days. During this
time they lose muscle bulk, develop gait abnormalities and display
changes in the spinal cord consistent with those seen in humans
with motor neuron disease, including loss of motor neurons,
perikaryal accumulation of neurofilaments and reactive gliosis [2].
Wasted mice also perform increasingly poorly on the rotarod over
the same period of time.
A number of mutations in mouse genes related to motor neuron
disease have been shown to have late-onset phenotypic effects in
heterozygotes, in contrast to a much more severe and/or early
onset phenotype in homozygotes. For example, mutations in the
dynein heavy chain in mice give rise to the ‘‘legs at odd angles’’
phenotype, characterised by motor neuron degeneration by
16 months, whereas homozygous mutant animals die within
24 hours after birth [8]. Similarly, a targeted mutation in the
Zpr1 gene (coding for a zinc finger protein, also called ZNF259) in
mice gives rise to an early embryonic lethal phenotype in
homozygous Zpr12/2 mice. In contrast, heterozygotes are viable;
they develop progressive motor neuron loss but not at a significant
level until 12 months of age [9]. Importantly, these mice display
progressive down-regulation of Zpr1 in brains; at 6 weeks there
was only a 15% reduction in expression compared to wild-type
tissues, but by 12 months the reduction was the expected 50%. As
ZPR1 has been shown to interact with eEF1A [10] and survival
motor neuron (SMN) proteins [11] (mutations of which cause
spinal muscular atrophy) we decided to investigate expression
levels of eEF1A2 in older wasted heterozygote (wst/+) mice, and to
establish whether they showed any signs of late onset motor
neuron degeneration.
We therefore set out to examine the effects of ageing on a
cohort of heterozygous +/wst mice together with wild-type
littermate controls, in order to establish whether a reduction in
eEF1A2 expression was compatible with normal function.
Although the wasted mutation was originally said to be recessive
on the basis that heterozygotes survived and bred, the only
pathological investigations that had been carried out previously
were on +/wst mice of less than a month old. Similarly, no
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expression analysis of eEF1A2 had been carried out on wasted
heterozygotes past 3 months of age.
We also set out to evaluate the use of a grip strength meter as a
way of distinguishing between wasted and wild-type mice at 3–
4 weeks, and then performed the same assay in older +/wst and
wild-type mice. Finally, we used performance on the rotarod and
immunohistochemistry of spinal cord sections to evaluate the
phenotype of aged heterozygous mice.
Materials and Methods
Mice
Mice were housed in the Biomedical Research Facility (BRF) at
the University of Edinburgh. All mice were maintained in
accordance with Home Office regulations and all protocols had
been approved by the local ethics committee of the University of
Edinburgh. All animals were housed in single sex cages but each
cage contained a mixture of both wild-type and heterozygous
animals.
Western Blotting
Western blotting was carried out as previously described [7]
using anti-eEF1A antibodies raised in sheep. Anti-eEF1A2 was
used at 1:2000.
In case the repeated exposure to the rotarod was masking any
difference between genotypes (because of beneficial effects of
exercise, or familiarity with the task), a second cohort was tested at
18 months only, again over a 5 day period. However, there were
still no statistically significant differences between genotypes (data
not shown).
Rotarod Analysis
Mice were placed on a rotating beam and their latency in falling
from the beam recorded. Mice were trained for 5 minutes at a
constant speed of 4 rpm, followed by a 30 minute rest period, and
then tested 3 times at accelerating speed (4–40 rpm over
5 minutes) with 15 minute recovery periods in between each test.
Mice were tested on alternate days over a fortnight. To ensure
animals did not require extensive re-training at the start of each
testing month, between testing periods mice were trained once a
week for 5 minutes on the rotarod set to a constant speed of 4 rpm
to maintain familiarity with the procedure. All rotarod data were
collected blind. At the start of each testing session mice were
monitored for several minutes and weighed to check for any
obvious mobility or other health problems. Once mice were
deemed healthy training commenced. If however a mouse showed
any signs of illness they were immediately removed from the study
and all data for that animal for that given month was excluded.
Grip Strength Meter
A grip strength meter from Bioseb was used for this assay. Mice
were tested for muscle strength in forelimbs only and then in all
four limbs. To account for variation in body weight all grip
strength readings (measured in Newtons) were normalised to body
weight (measured in grams).
Immunohistochemistry
Immunohistochemistry was carried out as previously described
[7]. Antibodies used were eEF1A2 [7] used at 1:10 dilution, anti-
GFAP raised in rabbit (Dako) at 1:1000 and anti-NF-H raised in
mouse (Dako) and 1:80. Spinal cord sections (4 microns) were
stained with eEF1A2 and motor neurons of the anterior horn
section of the spinal cord (as defined by Fischer et al [12] ) were
counted. One section was counted at each level for each mouse
(4–6 mice, as shown in table 1).
Results
Mice
A cohort of ageing male and female +/wst heterozygous mice
together with male and female wild-type controls was established.
Four groups of 8 animals were bred from 3 breeding pairs. Mice
were selected from the first two litters of each breeding pair, thus
there were slight differences in age of some of the litters but this
was no greater than 1 month; all tests were conducted when the
youngest mice were of the required age. The entire cohort was
tested on the same day and all tests were carried out in the
morning. Motor function was assessed using an accelerating
rotarod and muscle function using a grip strength meter. Initially
these animals were tested at tri-monthly intervals to allow us to
pinpoint the starting time of any difference between wild-types and
heterozygotes. A subsequent cohort was aged to 18 months
consisting of 3 wild-type males, 3 heterozygous males, 3 wild-
type females and 4 heterozygote females with no testing until this
age.
No Differences in Rotarod Performance
Rotarod performance was analysed at tri-monthly time points
until 15 months of age, and then more frequently until 21 months.
As males and females perform differently in some behavioural
tasks such as the rotarod, data were analysed by genotype and also
by gender. The mean monthly fall times for each group are shown
Table 1. Motor neuron numbers from the spinal cords of the ageing cohort.
Group
Level of spinal
cord Number of mice Mean MN count Minimum MN count Maximum MN count Standard deviation
Male +/+ Cervical 6 30.3 17 45 9.4
Thoracic 6 33.3 16 49 12.6
Lumbar 4 26.3 19 38 8.4
Male +/wst Cervical 5 32.6 29 37 3.8
Thoracic 6 29.1 25 38 4.6
Lumbar 4 14.4 10 32 9.6
Mean motor neuron counts from spinal cord sections from the ageing cohort. WT indicates wild-type animals, HET indicates heterozygote animals N = number of
animals in the group, Mean = average of group, Min = minimum reading of group, max = maximum reading of group, S.D = standard deviation. No differences were
significant.
doi:10.1371/journal.pone.0041917.t001
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in Figure 1. No significant differences were observed between wild-
types and heterozygotes of either gender between the ages of 3 and
21 months of age. The data were also analysed by normalising the
mean times to body weight (data not shown) but again, no
significant difference was found between groups. The performance
of all four groups declined over the first 15 months, but then
improved when monthly testing was introduced.
Grip Strength is Sensitive to Total Loss of eEF1A2 but not
Haploinsufficiency
The results of the grip strength assay in wasted homozygous
mice and their normal littermates (both heterozygous and wild-
type mice) show a significant difference between wasted mice and
controls from 20 days in both the forelimbs only and in all four
Figure 1. Rotarod analysis of aged mice. Mean times of latency to fall from the rotarod over the 21 months of the ageing study. WT indicates
wild-type animals, HET indicates heterozygote animals. The upper graph shows data from the male groups and the lower graph shows data from the
female groups. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0041917.g001
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limbs (Figure 2). Oddly, for both sets of measurements, the
difference between wasted and control mice becomes at best
weakly significant at 21 days but returns to being highly significant
by 22 days. From 20 days onwards, at least 8 mice were tested in
each category. These results validate the grip strength meter as a
useful test for distinguishing wasted mice from their littermate
controls.
Having shown that this assay successfully distinguished wst/wst
mice from normal littermate controls, we went on to use it to
measure muscle function in heterozygotes and wild-type littermate
controls. Mice were tested tri-monthly from 3 months of age to
21 months of age. Readings were taken from forelimbs only and
from all four limbs combined. On a single test day, three readings
were taken for each assay. In any given testing month these tests
were carried out two days after the last rotarod test day.
Figure 3 shows the grip strength test results for the whole testing
period. Mean data for each animal were normalised to body
weight before combining the group data. There was no statistically
significant difference between any of the groups at any time point
over the course of the study. Until the mice reach 15 months, age
appears to have no effect on performance, but between 16–
18 months there appears to be an increase in performance in all
groups. This is most likely due to the increase in exercise the
animals received during this time period when the frequency of
rotarod testing was increased.
No Significant Pathology in Heterozygous Mice
Once the rotarod and grip strength experiments were termi-
nated, spinal cords were collected from the mice and analysed for
potential markers of motor neuron degeneration. Sections were
initially stained with an antibody that recognises phosphorylated
neurofilaments (both light and heavy chain). These proteins
typically accumulate in the perikarya of neurons in cases of motor
neuron degeneration; this effect is seen quite markedly in
homozygous wst/wst mice by 19 days [2]. No significant differ-
ences were observed between wild-type and heterozygous animals,
although clear perikaryal staining can be seen in a motor neuron
Figure 2. Grip strength analysis of young wasted mice. Forelimb (top panel) and all four limbs (bottom panel) grip strength analysis of wasted
mice. The daily grip strength reading of 3 tests (measured in Newtons) were normalised to body weight (measured in grams). P values were
calculated comparing wasted mice with controls (+/+ and +/wst combined). * indicates a P value,0.05, ** indicates a P value,0.01, and *** indicates
a P value ,0.001.
doi:10.1371/journal.pone.0041917.g002
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on the control section from a wasted homozygous mouse (Figure 4,
left hand panel and Figure S1).
Sections were also stained with an antibody for glial fibrillary
acidic protein (GFAP) as a marker of gliosis. In wasted mice
reactive gliosis is the earliest observable abnormality in the spinal
cord [2]. Although there were indications of reactive gliosis, as
characterised by numerous GFAP positive foci in the grey matter
of the spinal cord, no differences were observed in GFAP staining
between wild-types and heterozygotes (Figure 4, central panel and
Figure S1). As wasted mice display a rostrocaudal gradient of
gliosis, with the cervical region being more affected than the
thoracic and lumbar levels, all regions of the spinal cord were
examined in this study. However, no difference was seen at any
level of the spinal cord (data not shown).
Spinal cord sections were also analysed for expression of
eEF1A2, which was also used to stain motor neurons for counting.
Clear motor neuron-specific staining was seen, albeit at a slightly
reduced level in +/wst mice (Figure 4, right hand panel).
Finally, counts of motor neurons were conducted on the spinal
cord sections. No sign of vacuolation was seen in any case, and
there were no statistically significant differences in MN counts
between +/wst and +/+ male mice (Table 1), although the
numbers counted on different sections were highly variable. No
differences were seen in female mice either, but data are not shown
as only two female heterozygotes were available.
Expression Analysis of eEF1A2
As no pathological differences could be seen between wild-
type and heterozygous mice, we measured protein levels of
eEF1A2 in brain, spinal cord and muscle by Western blotting in
order to establish whether levels of eEF1A2 in heterozygotes
were really reduced to the predicted 50%, or whether some
compensatory mechanism had caused them to be increased
closer to wild-type levels. Three individuals from each of the
four groups were analysed at 21 months of age (Figure 5).
Expression of eEF1A2 does indeed appear to be decreased in
heterozygote animals relative to wild-type (both males and
females) in all three tissue types, but results were very variable,
in part because of the lower sample number caused by reduced
survival in the aged animals, and because there is clear
variability between individual animals. Analysis of further aged
mice showed the same very variable decrease in expression in
Figure 3. Grip strength analysis of aged mice. Grip strength data for the entire ageing study. Graphs on the left display male data and graphs
on the right display female data. Top graphs display forelimb data only and the bottom 2 graphs display data from all four limbs. WT indicates wild-
type animals, HET indicates heterozygote animals. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0041917.g003
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aged heterozygotes (data not shown). This analysis did establish,
however, that there had not been a compensatory increase in
eEF1A2 in heterozygous mice that could have accounted for the
absence of phenotypic abnormalities in the aged heterozygotes.
Indeed, it is apparent from these results that levels of
substantially less than 50% of those seen in wild-type mice
(only 7.5% in male heterozygous brains, for example) is
compatible with normal neuromuscular function.
Discussion
Total ablation of eEF1A2, as seen in wasted homozygous mice,
gives rise to an early onset and extremely aggressive phenotype
resulting in death by 4 weeks of age. This, together with the
fundamental housekeeping role of eEF1A2 in protein synthesis,
suggested that a decrease in eEF1A2 levels beyond a certain
threshold could compromise the function of motor neurons and/
or muscle. We therefore aged and analysed a cohort of
heterozygous wasted mice, presumed to have 50% of wild-type
expression levels.
Initially, we tested heterozygous and wild-type littermate mice
on the rotarod at a variety of ages, to assess gross motor function
and coordination. In these studies both wild-type and heterozy-
gous animals demonstrated improvement with practice in the
rotarod test, which could be attributed either to learning or to
beneficial effects of regular exercise. This is shown most clearly
when only one month elapsed between tests; here, performance in
all groups increased compared to performance in tests conducted
every three months. This is consistent with results obtained on
similar assays conducted on mice carrying the SOD1 G93A
mutation [13], with both wild-type controls and transgenic mice
showed evidence of learning. A further study demonstrated the
beneficial effects of exercise in the same line [14], with regular
treadmill exercise over a 10 week period significantly extending
the lifespan of the diseased animals. Another group showed that
exercise delayed the onset of disease in females but not in males
and had no affect on lifespan of either sex [15]. It is conceivable,
therefore, that regular exercise could mask any potential difference
between wild-types and heterozygous mice in this study. However,
the follow-up study, albeit on restricted numbers of animals, also
Figure 4. Immunohistochemistry in aged spinal cord sections. Expression of phosphorylated neurofilaments, GFAP, and eEF1A2 in cervical
spinal cord sections from 21 month old mice. The top panel in each case shows a section with primary antibody omitted from the protocol, the
second panel from the top shows sections from a 24 day old wasted homozygote as a control, and the bottom two panels show sections from an
aged matched wild-type and heterozygous male. The NF staining clearly shows perikaryal accumulation of NF staining in the wasted mouse section
but not in the aged +/wst mouse. The GFAP staining shows a characteristic pattern of reactive astrocytes throughout the grey matter of the spinal
cord, even in the aged wild-type mouse. The eEF1A2 shows no staining at all in the section from the wst/wst mouse as expected, and fainter but
easily detectable, albeit reduced, staining in the aged +/wst sample.
doi:10.1371/journal.pone.0041917.g004
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failed to show any difference between cohorts of different
genotypes even though the animals were not tested until
18 months of age. This suggests that there is genuinely no
difference in performance of wild-type and heterozygous mice.
This conclusion is supported by the grip strength analysis which,
although it proved to be a robust assay for distinguishing wasted
mice from their littermate controls, also failed to show any
difference between the groups of different genotype in the aged
cohort.
Further, we found no significant differences in terms of spinal
cord pathology between any of the groups examined using GFAP
and NFH as markers of neurodegeneration. It has been
demonstrated that levels of GFAP in the mouse central nervous
system increase with age, at least in the brain [16,17,18]. This may
explain the high level of staining in older wild-types that
complicated our analysis; we are not aware of any studies of
GFAP in ageing spinal cords. Motor neuron counts also
demonstrated no significant difference between groups. However,
animals were being lost for unrelated health reasons (similar
numbers of heterozygotes and wild-type mice) by this stage, so that
relatively few animals were available at the endpoint of the study.
Since the results also showed substantial variation between mice,
this aspect of the work could be regarded as inconclusive.
Expression analysis of eEF1A2 in the heterozygotes at the
end stage of this study showed that, depending on the sex of the
animals and the tissue studied, eEF1A2 levels in heterozygotes
relative to their wild-type littermates decline markedly with age
when compared to the results at four weeks published by
Khalyfa et al [19]. Recent results in other tissues such as heart
and hippocampus have concluded that only minor changes
occur in the mouse proteome as a whole during aging [20], but
as this study did not examine skeletal muscle it is impossible to
judge whether our result is a feature of muscle, or is protein-
specific.
It is interesting to compare our results on eEF1A2 with those
found for Zpr1 knockout mice. In this case, heterozygous Zpr1+/
2 mice do show some reduced expression when compared to
wild-type controls, albeit less than predicted [9], and this
reduction in level becomes more marked with age. However, in
contrast to eEF1A2 where levels are found at the predicted 50%
of wild-type in younger heterozygous mice [19], ZPR1 levels in
the brains of heterozygous Zpr1+/2 knockout mice start at
almost 90% of wild-type levels, declining to 30% by 12 months
of age. Whilst 6 week old heterozygotes showed no marked
decrease in motor neuron number compared to wild type
controls, by 12 months of age heterozygous mice display
reduced cell density and loss of anterior horn motor neurons
compared to wild-types. This correlates directly with the
decrease in ZPR1 protein with age. ZPR1 has been shown to
preferentially bind to GDP bound eEF1A [21]. As eEF1A2 has
a slower disassociation rate than eEF1A1 it is possible that
ZPR1 preferentially binds eEF1A2. It is therefore plausible that
in ageing wasted heterozygotes the reduced levels of eEF1A2
result in insufficient ZPR1-eEF1A complexes. An interesting
avenue for future work would be to examine whether any
changes occur in the levels or localization of ZPR1 and SMN in
older heterozygous +/wst animals, which would contribute to
further our understanding of the interaction between these three
proteins. Crosses between Zpr1+/2 and Eef1a2+/2 mice could
also be carried out, to establish whether decreased levels of both
eEF1A2 and ZPR1 can compromise motor neuron function
further.
Figure 5. Protein expression in aged mice. Western blots showing protein expression of eEF1A2 and GAPDH (as a loading control) of animals
from the ageing cohort. Three 21month old animals from each group are shown. WT indicates wild-type animals, HET indicates heterozygous
animals, M indicates a muscle sample (as an eEF1A2 positive control) and L indicates a liver sample (an eEF1A2 negative control), both from wild-type
mice.
doi:10.1371/journal.pone.0041917.g005
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Supporting Information
Figure S1 Higher resolution images of GFAP and NF-H
staining in aged heterozygous and wild-type mice.
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